MYRIAD GENETICS INC — Director's Dealing 2018

Jul 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-07-11

Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-11	Common Stock	M	46139	$30.34	Acquired	184948	Direct
2018-07-11	Common Stock	S	46139	$43.3408	Disposed	138809	Direct
2018-07-11	Common Stock	M	3861	$30.34	Acquired	142670	Direct
2018-07-11	Common Stock	S	3861	$43.3408	Disposed	138809	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-11	Incentive Stock Option (right to buy)	$30.34	M	3861	Disposed	2019-09-15	Common Stock (3861)	Direct
2018-07-11	Non-Qualified Stock Option (right to buy)	$30.34	M	46139	Disposed	2019-09-15	Common Stock (46139)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.